The "Louisiana Addendum to Caremark Provider Agreement", beginning on page 98 of the Caremark Provider Manual, is amended to add the following new section, after section 5, as follows:

Effective immediately, the “Non-Statin Cholesterol PDC” adherence measure is no longer an adherence measure for the CVS/caremark Adherence Improvement Program.

The generic for AGGRENOX® recently became available in the marketplace; however, select Medicare Part D plans adjudicating claims through CVS/caremark will continue to cover the brand name AGGRENOX® at the Preferred Brand or Generic Tier copayment.

The MCO (Managed Care Organizations for Medicaid) requires that you have the option to be notified in advance of changes to the generic pricing utilized for West Virginia Family Health beneficiaries.

Please use the attached referenced information when processing claims for H&F Manufacturing and PHX Broadband Tech. These Catamaran plans must be processed as the secondary payer.